Biosimilars: potential implications for clinicians
Misty G Eleryan,1 Sophia Akhiyat,2 Monica Rengifo-Pardo,1 Alison Ehrlich,1,2 1Department of Dermatology, The George Washington Medical Faculty Associates, 2George Washington University School of Medicine & Health Sciences, Washington, DC, USA Abstract: With the expiration of patent protection fo...
Saved in:
Main Authors: | Eleryan MG (Author), Akhiyat S (Author), Rengifo-Pardo M (Author), Ehrlich A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge, Attitude and Practice on Biologicals and Biosimilars among Clinicians in Radiotherapy Department
by: Manju Agrawal, et al.
Published: (2023) -
A case of eosinophilic annular erythema as a presenting sign for autoimmune hepatitis
by: Olabola Awosika, MD, MS, et al.
Published: (2018) -
Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
by: Awosika O, et al.
Published: (2018) -
The Clinical Implications of Nocebo Effects for Biosimilar Therapy
by: Luana Colloca, et al.
Published: (2019) -
Biosimilars and implications for pharmacy practice: Ready or not, here they come!
by: Hobbs AL, et al.
Published: (2019)